Skip to main content

Advertisement

Log in

Inhibition of experimental angiogenesis of cornea by somatostatin

  • Laboratory Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background.

This study evaluated the inhibitory activity of somatostatin 14 on the angiogenesis of cornea in vivo.

Methods.

Corneal neovascularization was induced with a pellet containing 90 ng of basic fibroblast growth factor (bFGF) in a rat corneal pocket model. Three kinds of pellets were made containing bFGF plus somatostatin (SST) 0 ng, 20 ng and 200 ng for the control group, group 1 and group 2, respectively. Neovascularization was observed biomicroscopically from day 4 to day 8, and the corneas were then examined for changes in histology. Quantitation of angiogenesis in the cornea was accomplished by caliper and image analysis.

Results.

The 200-ng dose of SST showed significant inhibition of both length and area of neovascularization on day 7 (0.62±0.11 mm vs 1.29±0.16 mm, 0.50±0.16 mm2 vs 1.35±0.29mm2, group 2 vs control; P <0.05). The 20 ng of somatostatin did not demonstrate any significant inhibition of neovascularization compared with the control group.

Conclusion.

Our study demonstrated that SST 14 can reduce bFGF-induced corneal angiogenesis. This shows the potential value of somatostatin in the treatment of corneal neovascularization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1a–c.
Fig. 2a, b.
Fig. 3.

Similar content being viewed by others

References

  1. Adamis AP, Meklir B, Joyce NC (1991) In situ injury-induced release of basic-fibroblast growth factor from corneal endothelial cells. Am J Pathol 139:961–966

    CAS  PubMed  Google Scholar 

  2. Akbar M, Okajima F, Tomura H, Majid MA, Yamada Y, Seino S, Kondo Y (1994) Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1–5, in transfected COS-7 cells. FEBS Lett 348:192–196

    Article  CAS  PubMed  Google Scholar 

  3. Barrie R, Woltering EA, Hajarizadeh H, Mueller C, Ure T. Fletcher WS (1993) Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. J Surg Res 55:446–450

    Article  CAS  PubMed  Google Scholar 

  4. Bell GI, Reisine T (1993) Molecular biology of somatostatin receptors. Trends Neurosci 16:34–38

    CAS  PubMed  Google Scholar 

  5. Benelli U, Bocci G,. Danesi R, Lepri A, Bernardini N, Bianchi F, Lupetti M, Dolfi A, Campagni A, Agen C, Nardi M, Del Tacca M (1998) The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization. Exp Eye Res 67:133–142

    Article  CAS  PubMed  Google Scholar 

  6. Bocci G, Danesi R, Benelli U, Innocenti F, Di Paolo A, Fogli S, Del Tacca M (1999) Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo. Cancer Chemother Pharmacol 43:205–212

    Article  CAS  PubMed  Google Scholar 

  7. Buscail L, Delesque N, Esteve JP, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV (1994) Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci U S A 91:2315–2319

    CAS  PubMed  Google Scholar 

  8. D'Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A 91:4082–4085

    CAS  PubMed  Google Scholar 

  9. Danesi R, Agen C, Benelli U, Paolo AD, Nardini D, Bocci G, Basolo F, Campagni A, Tacca MD (1997) Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201–995). Clin Cancer Res 3:265-272

    CAS  PubMed  Google Scholar 

  10. Florio T, Rim C, Hershberger RE, Loda M, Stork PJ (1994) The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol Endocrinol 8:1289–1297

    CAS  PubMed  Google Scholar 

  11. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A 90:2690–2694

    CAS  PubMed  Google Scholar 

  12. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364

    PubMed  Google Scholar 

  13. Hayashi N, Nakayasu K, Okisaka S (1996) Immunohistochemical localization of acidic and basic fibroblast growth factor through corneal neovascularization in vivo and in vitro. Nippon Ganka Gakkai Zasshi 100:587–591

    CAS  PubMed  Google Scholar 

  14. Higgins RD, Yan Y, Schrier BK (2002) Somatostatin analogs inhibit neonatal retinal neovascularization. Exp Eye Res 2002 74:553–559.

    Article  CAS  Google Scholar 

  15. Hill JC, Maske R (1988) An animal model for corneal graft rejection in high-risk keratoplasty. Transplantation 46:26–30

    CAS  PubMed  Google Scholar 

  16. Holz FG, Krastel H, Breitbart A, Schwarz-Eywill M, Pezzutto A, Volcker HE (1992) Low-dose methotrexate treatment in noninfectious uveitis resistant to corticosteroids. Ger J Ophthalmol 1:142–144

    CAS  PubMed  Google Scholar 

  17. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ (1996) A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 37:1625–1632

    CAS  PubMed  Google Scholar 

  18. Klein-Soyer C, Beretz A, Cazenave JP, Driot F, Maffrand JP (1990) Behavior of confluent endothelial cells after irradiation. Modulation of wound repair by heparin and acidic fibroblast growth factor. Biol Cell 68:231-238

    CAS  PubMed  Google Scholar 

  19. Klisovic DD, O'Dorisio MS, Katz SE, Sall JW, Balster D, O'Dorisio TM, Craig E, Lubow M (2001) Somatostatin receptor gene expression in human ocular tissues: RT-PCR and immunohistochemical study. Invest Ophthalmol Vis Sci 42:2193–2201

    CAS  PubMed  Google Scholar 

  20. Lawnicka H, Stepien H, Wyczolkowska J, Kolago B, Kunert-Radek J, Komorowski J (2000) Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture. Biochem Biophys Res Commun 268:567–571

    Article  CAS  PubMed  Google Scholar 

  21. Li WW, Grayson G, Folkman J, D'Amore PA (1991) Sustained-release endotoxin. A model for inducing corneal neovascularization. Invest Ophthalmol Vis Sci 32:2906–2911

    CAS  PubMed  Google Scholar 

  22. Liebow C, Reilly C, Serrano M, Schally AV (1989) Somatostatin analogues inhibit growth of pancreaic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci U S A 86:2003–2007

    CAS  PubMed  Google Scholar 

  23. Mallet B, Vialettes B, Haroche S, Escoffier P, Gastaut P, Taubert JP, Vague P (1992) Stabilization of severe proliferative diabetic retinopathy by long-term treatment with SMS 201–995. Diabete Metabolisme 18:438–444

    CAS  PubMed  Google Scholar 

  24. Patel PC, Barrie R, Hill N, Landeck S, Kurozawa D, Woltering EA (1994) Postreceptor signal transduction mechanisms involved in octreotide-induced inhibition of angiogenesis. Surgery 116:1148–1152

    CAS  PubMed  Google Scholar 

  25. Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20:157–198

    CAS  PubMed  Google Scholar 

  26. Patel YC, Greenwood MT, Warszynska A, Panetta R, Srikant CB (1994) All five cloned human somatostatin receptors (hSSTR1–5) are functionally coupled to adenylyl cyclase. Biochem Biophys Res Commun 198:605–612

    Article  CAS  PubMed  Google Scholar 

  27. Pawlikowski M, Lachowicz L, Kunert-Radek J, Winczyk K, Janiszewska G, Szkudlarek J (1998) Differential effects of somatostatin and its analog on protein tyrosine kinases activity in the rat pituitary and the murine colonic tumors. Biochem Biophys Res Commun 246:375–377

    Article  CAS  PubMed  Google Scholar 

  28. Reubi JC, Laissue JA (1995) Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol Sci 16:110–115

    Article  CAS  PubMed  Google Scholar 

  29. Woltering EA, Watson JC, Alperin-Lea RC, Sharma C, Keenan E, Kurozawa D, Barrie R (1997) Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action. Invest New Drugs 15:77–86

    Article  CAS  PubMed  Google Scholar 

  30. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S (1992) Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci U S A 89:251–255.

    CAS  PubMed  Google Scholar 

  31. Yasuda K, Rens-Domiano S, Breder CD, Law SF, Saper CB, Reisine T, Bell GI (1992) Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase. J Biol Chem 267:20422–20428

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements.

This work was supported by a project grant from Chang Gung Memorial Hospital Grand CMRP and National Science Council Grand NMRP. The authors thank Professor Nina Gloriani Barzaga for reading and editing the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lin-Cheng Yang.

Additional information

The first, second, and third authors contributed equally

No commercial relationship

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, PC., Liu, CC., Chen, Ch. et al. Inhibition of experimental angiogenesis of cornea by somatostatin. Graefe's Arch Clin Exp Ophthalmol 241, 63–69 (2003). https://doi.org/10.1007/s00417-002-0591-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-002-0591-7

Keywords

Navigation